Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.906
+0.046 (2.47%)
Sep 5, 2025, 4:00 PM - Market closed

APUS Statistics

Total Valuation

APUS has a market cap or net worth of $23.97 million. The enterprise value is $15.73 million.

Market Cap23.97M
Enterprise Value 15.73M

Important Dates

The last earnings date was Tuesday, August 19, 2025, after market close.

Earnings Date Aug 19, 2025
Ex-Dividend Date n/a

Share Statistics

APUS has 12.58 million shares outstanding. The number of shares has increased by 28.67% in one year.

Current Share Class 12.58M
Shares Outstanding 12.58M
Shares Change (YoY) +28.67%
Shares Change (QoQ) +31.19%
Owned by Insiders (%) 18.06%
Owned by Institutions (%) 1.87%
Float 3.05M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.46
P/TBV Ratio 2.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.79, with a Debt / Equity ratio of 0.05.

Current Ratio 12.79
Quick Ratio 10.80
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -27.77

Financial Efficiency

Return on equity (ROE) is -82.20% and return on invested capital (ROIC) is -45.40%.

Return on Equity (ROE) -82.20%
Return on Assets (ROA) -42.42%
Return on Invested Capital (ROIC) -45.40%
Return on Capital Employed (ROCE) -37.01%
Revenue Per Employee n/a
Profits Per Employee -$1.85M
Employee Count2
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 1.82
200-Day Moving Average n/a
Relative Strength Index (RSI) 52.51
Average Volume (20 Days) 188,272

Short Selling Information

The latest short interest is 3,216, so 0.03% of the outstanding shares have been sold short.

Short Interest 3,216
Short Previous Month 10,359
Short % of Shares Out 0.03%
Short % of Float 0.11%
Short Ratio (days to cover) 0.01

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -3.60M
Pretax Income -1.42M
Net Income -3.71M
EBITDA n/a
EBIT -3.60M
Earnings Per Share (EPS) -$0.43
Full Income Statement

Balance Sheet

The company has $8.74 million in cash and $500,100 in debt, giving a net cash position of $8.24 million or $0.65 per share.

Cash & Cash Equivalents 8.74M
Total Debt 500,100
Net Cash 8.24M
Net Cash Per Share $0.65
Equity (Book Value) 9.74M
Book Value Per Share 0.77
Working Capital 9.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$3.67 million and capital expenditures -$13,369, giving a free cash flow of -$3.68 million.

Operating Cash Flow -3.67M
Capital Expenditures -13,369
Free Cash Flow -3.68M
FCF Per Share -$0.29
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

APUS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -28.67%
Shareholder Yield -28.67%
Earnings Yield -15.47%
FCF Yield -15.36%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2